Global Medical REIT Inc.

NYSE GMRE

Global Medical REIT Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2024: USD 100.67 M

Global Medical REIT Inc. EBITDA is USD 100.67 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 143.48% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Global Medical REIT Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 41.35 M, a -6.58% change year over year.
Global Medical REIT Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 44.26 M, a -42.78% change year over year.
Global Medical REIT Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 77.35 M, a 65.20% change year over year.
Global Medical REIT Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 46.82 M, a -0.95% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

NYSE: GMRE

Global Medical REIT Inc.

CEO	Mr. Jeffrey M. Busch J.D.
IPO Date	June 30, 2016
Location	United States
Headquarters	2 Bethesda Metro Center
Employees	26
Sector	Health Care
Industries Hospitals & Clinics Telehealth

Description

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.

Key trends

Past 5 years